Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
LDLR- |
RCV000237724 | SCV000295593 | likely pathogenic | Hypercholesterolemia, familial, 1 | 2016-03-25 | criteria provided, single submitter | literature only | |
Centre de Génétique Moléculaire et Chromosomique, |
RCV000237724 | SCV000503392 | pathogenic | Hypercholesterolemia, familial, 1 | 2016-12-16 | criteria provided, single submitter | clinical testing | subject mutated among 2600 FH index cases screened = 1 |
Cardiovascular Research Group, |
RCV000237724 | SCV000599384 | pathogenic | Hypercholesterolemia, familial, 1 | 2016-03-01 | criteria provided, single submitter | curation | |
Centre for Mendelian Genomics, |
RCV000237724 | SCV001366193 | pathogenic | Hypercholesterolemia, familial, 1 | 2020-01-30 | criteria provided, single submitter | clinical testing | This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PS1,PS3,PM2. |
Gene |
RCV004701339 | SCV005201890 | pathogenic | not provided | 2023-07-19 | criteria provided, single submitter | clinical testing | Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 7635482, 33955087, 33740630) |
Mayo Clinic Laboratories, |
RCV004701339 | SCV005413318 | pathogenic | not provided | 2023-08-29 | criteria provided, single submitter | clinical testing | PM2, PS3_moderate, PS4_moderate, PVS1 |
Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, |
RCV000237724 | SCV000606490 | pathogenic | Hypercholesterolemia, familial, 1 | no assertion criteria provided | research |